Dr. Lecia Sequist provides her thoughts on how molecular oncology can soon begin affecting treatment plans for a broader range of patients with lung cancer, including those with squamous NSCLC and other lung cancer histologies.
Podcast: Play in new window
| Download (Duration: 1:04 — 12.4MB)
You must be logged in to post a comment.
Mission | Disclaimer